Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2048 studies found for:    "Endocrine Gland Neoplasms"
Show Display Options
Rank Status Study
21 Completed Evaluation of Blood Vessel Formation in Endocrine Tumors
Condition: Lesions
Intervention:
22 Not yet recruiting Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor
Conditions: Pancreatic Tumor;   Endocrine Tumor;   Neoplasms, Cystic, Mucinous, and Serous
Intervention: Procedure: Radiofrequency Ablation under EUS
23 Recruiting Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
Conditions: Sarcoma;   Endocrine Tumors;   Neuroblastoma;   Retinoblastoma;   Renal Cancer
Intervention:
24 Terminated Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia
Conditions: Colon Tumors;   Rectum Tumors;   Appendix Tumors;   Peritoneum Tumors;   Endocrine Tumors
Intervention: Drug: Oxaliplatin and irinotecan
25 Completed Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
Conditions: Carcinoma;   Carcinoma, Renal Cell;   Neuroendocrine Tumors;   Carcinoid Tumor;   Pancreatic Islet Cell Tumors
Intervention: Other: Blood sampling by vena punction.
26 Recruiting Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors
Conditions: Neuroendocrine Tumors;   Hepatic Metastases;   Metastases
Interventions: Drug: Everolimus;   Device: embolization;   Drug: Doxorubicin
27 Recruiting PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation
Condition: Neuroendocrine Tumors
Intervention: Procedure: 68Ga-DOTATOC PET-CT Imaging
28 Terminated
Has Results
Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors
Condition: Pancreatic Cancer
Interventions: Drug: Avastin;   Drug: Fluorouracil;   Drug: Doxorubicin;   Drug: Streptozocin;   Drug: Dexamethasone;   Drug: Ondansetron
29 Recruiting RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe
Conditions: Carcinoma;   Neuroendocrine;   Non Functioning Neuroendocrine Tumors/NET;   Non Syndromic Neuroendocrine Tumors/NET;   Carcinoids;   Non Functioning
Intervention: Drug: Everolimus
30 Recruiting Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs
Condition: Well Differentiated Pancreatic Endocrine Tumor
Intervention: Drug: Everolimus plus Octreotide LAR plus Metformin
31 Completed
Has Results
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.
Condition: Neoplasms
Interventions: Drug: bevacizumab [Avastin];   Drug: 5 FU;   Drug: Streptozotocin;   Drug: Xeloda
32 Completed Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)
Conditions: Muscle Rigidity;   Spasm;   Stiff Man Syndrome
Intervention: Drug: IVIg
33 Completed Vancomycin Associated Red Man Syndrome (RMS)
Condition: Red Man Syndrome
Intervention:
34 Recruiting Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca
Condition: Stage IV Pancreatic Cancer
Intervention: Drug: Ascorbic Acid
35 Recruiting ImmunoTEP for Patients With Medullary Thyroid Carcinoma.
Condition: Medullary Thyroid Carcinoma
Intervention: Drug: • TF2 and 68 Ga-IMP-288
36 Unknown  Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery
Conditions: Gastrointestinal Carcinoid Tumor;   Islet Cell Tumor;   Neoplastic Syndrome
Interventions: Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium
37 Unknown  Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Liver Cancer;   Neuroblastoma;   Ovarian Cancer;   Sarcoma;   Testicular Germ Cell Tumor
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
38 Enrolling by invitation Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: Cytoreductive Surgery (CRS);   Procedure: Hyperthermic Intraperitoneal Chemotherapy (HIPEC);   Drug: Systemic Chemotherapy
39 Completed Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors
Condition: Pancreatic Neuroendocrine Tumors (pNET)
Interventions: Drug: BEZ235;   Drug: Everolimus
40 Recruiting A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer
Condition: Ovarian Cancer, Pancreatic Cancer
Interventions: Drug: DMCU4064A;   Drug: DMUC4064A

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years